Etiology and prevention of cervical adenocarcinomas.

Adenocarcinomas of the uterine cervix (ACs) constitute a relatively rare histologic form of cervical cancer. However, while rates of the more common squamous cell carcinomas of the cervix (SCC) have shown consistent declines in incidence over time in countries where effective cytological screening programs exist, rates of AC have increased over the same period ( 1 – 3 ) . This has led to an increase in the proportion of cervical cancers attributable to AC in many countries. In the United States, ACs now make up more than 20% of all cervical cancer cases diagnosed each year ( 4 ) . The underlying reasons for the increases observed for AC are not well understood. They are likely due to a complex interplay between temporal changes in exposures that predispose to the development of AC and changes in cervical cancer screening practices ( 1 ) . Changes in screening practices and their likely impact on AC rates are in themselves diffi cult to understand because they include changes that are likely to have countervailing effects on disease rates. For example, increased awareness of AC, improved diagnostic classifi cation of these conditions, and improvements in cervical sampling devices and slide preparation methods might initially result in increased detection of invasive AC. These improvements would also lead to increased detection of AC at an earlier — in situ — state, which would subsequently lead to decreases in overall rates of invasive AC. Unlike the situation with SCC, however, this predicted long-term impact of improved screening on AC rates might be muted by limitations resultant from the diffi culty of detecting AC, which often arise deep in the endocervical canal, in areas that despite the improvements in screening alluded to above are still not easily sampled during routine screening. In this issue of the Journal, Castellsague and colleagues report fi ndings from a multicenter study of AC ( 5 ) . The results have important implications for our understanding of both the causes and possible prevention of AC. Each of these aspects is discussed below.

[1]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[2]  V. Beral,et al.  Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies , 2006, International journal of cancer.

[3]  Xavier Castellsagué,et al.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. , 2006, Journal of the National Cancer Institute.

[4]  F. Bray,et al.  Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries , 2005, Cancer Epidemiology Biomarkers & Prevention.

[5]  Cosette M Wheeler,et al.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. , 2005, The Lancet. Oncology.

[6]  F. Bray,et al.  Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening , 2005, Cancer Epidemiology Biomarkers & Prevention.

[7]  Daron G Ferris,et al.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial , 2004, The Lancet.

[8]  A. Berrington de González,et al.  Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis , 2004, British Journal of Cancer.

[9]  M. Sherman,et al.  Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000 , 2004, Cancer.

[10]  J. T. Cox,et al.  Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening , 2004, Obstetrics and gynecology.

[11]  L. Brinton,et al.  Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States) , 2001, Cancer Causes & Control.

[12]  V. Beral,et al.  Cervical cancer and use of hormonal contraceptives: a systematic review , 2003, The Lancet.

[13]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[14]  V. Moreno,et al.  Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study , 2002, The Lancet.

[15]  C. Key,et al.  The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. , 2000, Gynecologic oncology.